EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

EUS-Guided Liver Biopsy and Portal Pressure Measurement Compared With a Transjugular Approach: A Randomized Controlled Trial

Amine Benmassaoud, Ali Bessissow, Gordan Samoukovic, Philip Wong, Xun Zhao, Marc Deschenes, Giada Sebastiani, Tatiana Cabrera, David Valenti, Louis-Martin Boucher, Jean-Pierre Pelage, Karl Muchantef und 12 weitere

Clinical Gastroenterology and Hepatology · 2026-06 · 24 (6) · 1601-1610

DOI: 10.1016/j.cgh.2025.09.025 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-06. Verfasst von Amine Benmassaoud und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada; Research Institute of the McGill University Health Ce…. Hauptthemen laut MEDLINE: Endosonography, Portal Pressure, Hypertension, Portal, Liver. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Quebec Health Research Fund, McGill University Faculty of Medicine and Health Sciences, McGill University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: The transjugular (TJ) technique is recommended for the simultaneous evaluation of portal hypertension and hepatic fibrosis, with the hepatic venous pressure gradient (HVPG) and liver biopsy (LB), respectively. Unfortunately, technical challenges have restricted access to HVPG, and TJ LB is often of suboptimal quality. Endoscopic ultrasound (EUS) is a novel approach capable of obtaining portal pressure gradient (PPG) and LB. Our aim was to compare EUS-guided PPG LB with TJ HVPG LB. METHODS: Patients with chronic liver disease simultaneously evaluated for portal hypertension and liver fibrosis at the McGill University Health Centre were randomly assigned to EUS-guided PPG LB or TJ HVPG LB. The primary endpoint was the combination of adequate LB (guideline recommendation: ≥25 mm total length and ≥11 complete portal tracts) and reliable HVPG/PPG (expert consensus: 2 measures within ≤1 mm Hg). Secondary endpoints assessed technical success, LB quality, HVPG/PPG reliability, patient satisfaction, and adverse events. Intention-to-treat analyses were conducted. RESULTS: Fifty-eight patients were randomized; 29 were EUS and 29 were TJ. Technical success was 90.0% for EUS and 96.6% for TJ (relative risk [RR], 0.93; 95% confidence interval [CI], 0.81-1.07). Combined adequate LB and reliable HVPG/PPG was 82.8% for EUS and 41.4% for TJ (RR, 2.00; 95% CI, 1.26-3.18). Proportion of adequate LB was 93.1% for EUS and 41.4% for TJ (RR, 2.25; 95% CI, 1.44-3.51). Proportion of reliable HVPG/PPG was 89.7% for EUS and 58.6% for TJ (RR, 1.53; 95% CI, 1.10-2.13).We found no between-group difference in adverse events. CONCLUSIONS: EUS is superior to TJ for simultaneous acquisition of adequate LB and reliable PPG, suggesting that it has an important role in evaluating chronic liver diseases. CLINICALTRIALS: gov, Number: NCT05118308.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndosonographyPortal PressureHypertension, PortalLiverLiver CirrhosisHumansMaleFemaleMiddle AgedAdultAgedBiopsy

Stichwörter der Autor:innen

EndoscopyLiver BiopsyPortal HypertensionPortal Pressure Gradient

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada; Research Institute of the McGill University Health Centre, Montreal, Canada. Electronic address: amine.benmassaoud@mcgill.c…
  • Division of Interventional Radiology, McGill University Health Centre, Montreal, Canada.
  • Department of Surgery, McGill University Health Centre, Montreal, Canada.
  • Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada.
  • Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada; Research Institute of the McGill University Health Centre, Montreal, Canada.
  • Gastroenterology and Liver Transplant Unit, Institut de Malalties Digestives i Metaboliques, Hospital Clinic and University of Barcelona, Spain. Ciber de Enfermedades Hepáticas y Digestivas, Spain and Institut d'Investi…

Förderung

  • Quebec Health Research Fund
  • McGill University Faculty of Medicine and Health Sciences
  • McGill University
  • McGill University Health Centre

Zitieren

APA

Benmassaoud, A., Bessissow, A., Samoukovic, G., Wong, P., Zhao, X., Deschenes, M., Sebastiani, G., Cabrera, T., Valenti, D., Boucher, L. M., Pelage, J. P., Muchantef, K., Cardenas, A., Givis, M. A., White, S., Bousquet-Dion, G., Waked, C., Jacques, J., Rahme, E., …, & Chen, Y. I. (2026). EUS-Guided Liver Biopsy and Portal Pressure Measurement Compared With a Transjugular Approach: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 24(6), 1601-1610. https://doi.org/10.1016/j.cgh.2025.09.025

Vancouver

Benmassaoud A, Bessissow A, Samoukovic G, Wong P, Zhao X, Deschenes M, et al. EUS-Guided Liver Biopsy and Portal Pressure Measurement Compared With a Transjugular Approach: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 2026;24(6):1601-1610. doi:10.1016/j.cgh.2025.09.025

BibTeX
@article{Benmassaoud2026,
  author = {Benmassaoud, Amine and Bessissow, Ali and Samoukovic, Gordan and Wong, Philip and Zhao, Xun and Deschenes, Marc and Sebastiani, Giada and Cabrera, Tatiana and Valenti, David and Boucher, Louis-Martin and Pelage, Jean-Pierre and Muchantef, Karl and Cardenas, Andres and Givis, Mary Anne and White, Sheryl and Bousquet-Dion, Guillaume and Waked, Catherine and Jacques, Jeremie and Rahme, Elham and Geraci, Olivia and Martel, Myriam and Barkun, Alan and Maedler-Kron, Chelsea and Chen, Yen-I},
  title = {EUS-Guided Liver Biopsy and Portal Pressure Measurement Compared With a Transjugular Approach: A Randomized Controlled Trial},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {6},
  pages = {1601--1610},
  doi = {10.1016/j.cgh.2025.09.025}
}
Kostenlos starten →